Key Takeaways
- Strong revenue, flat EBITDA: Revenue grew 35% YoY to ₹1,807 Cr, but EBITDA rose only 1% as high-cost PVC inventory carried from Q3 compressed margins.
- PVC margins are a tale of two halves: Suspension PVC contribution averaged ~₹22,600/ton for Q4, dragged down by the first two months at ~₹18,000/ton before rebounding to ~₹29,000/ton in the final month as high-cost inventory cleared.
- Custom manufacturing is capacity-constrained: The CMC business grew revenue "slightly above 50%" in FY22, but FY23 growth is capped at 20% until the new multipurpose block comes online in early FY24.
- A capex cycle is loading: Management is "seriously looking at" additional capex beyond announced projects and expects to present a clear capital allocation plan within a couple of quarters.
- What to watch next quarter: Whether the China lockdown-driven PVC price pressure in Q1 FY23 reverses as quickly as management expects, and whether the promised capex clarity materializes.
PVC: Margin Mechanics & the China Overhang
- The delta, not the price, is the story: The spread between suspension PVC and VCM prices held stable at $325–$400/ton through Oct 2021 to Apr 2022, insulating the business from absolute price swings. Month-on-month margin variation comes from the 30–45 day feedstock arrival lag: a rising market helps, a falling market hurts for that window.
- Q4 margin walk: Suspension PVC contribution was ~₹22,600/ton overall, but the average conceals a sharp intra-quarter recovery. The first two months averaged ~₹18,000/ton as high-cost inventory carried from Q3 was consumed; March alone hit ~₹29,000/ton once that inventory cleared.
- China lockdowns are the near-term risk: COVID lockdowns in China are pushing excess PVC exports into the region, pressuring prices. Feedstock prices are also falling, but the benefit will only arrive after the 30–45 day lag. Management expects Q1 FY23 to be affected, but sees lockdowns potentially winding down by end-May, which would reverse the situation quickly.
- Paste PVC gross margin: Q1 will also see some China-driven impact, but management is "very confident" that from Q2 onwards margins will revert to normal FY22 levels.
- Medium-term structural tightness: IHS Markit estimates 0.9 Cr tons of demand growth vs 0.4 Cr tons of supply growth over five years, pushing operating rates above 93%. Carbide PVC plants in China face stress from mercury and carbon issues. India is already deficit by ~0.2 Cr tons.
Ramkumar Shankar: "The spreads are more or less stable between $325 to $400 - the individual price levels may have changed from 1900 to 1500 and so on, but the spreads remain pretty much stable and given the structural imbalance that I just spoke about, we are pretty confident that this spread would tend to continue."
Custom Manufacturing: Growth Engine on a Leash
- FY22 was a breakout year: CMC revenue grew "slightly above 50%," significantly exceeding the ~35% historical trajectory. Growth was driven primarily by volume from existing products plus two new products commercialized during the year.
- Margins held their ground: Contribution margin stayed roughly in the 40%–50% range despite significant cost pressures. Formula pricing arrangements with customers allowed reasonable pass-through of input cost increases, and cost pressures are expected to continue.
- FY23 is a capacity-constrained year: Growth will be "reasonably limited" and not expected to cross 20%, because the business is more or less out of capacity. Limited debottlenecking will help accommodate some new products, but significant growth waits on Phase 1 expansion.
- The expansion unlocks the next leg: The first phase of the new multipurpose block is slated for completion by Q1 FY2024. With ~₹340 Cr investment and an asset turn of ~2, incremental revenue of ~₹700 Cr is expected, taking total CMC revenue closer to ₹1,000 Cr once ramped up.
- Customer status upgrade: One customer upgraded Chemplast to "development supplier" status, meaning pipeline projects and new molecules from that customer will be routed to Chemplast as the first supplier.
Caustic Soda & Chloromethanes: Tailwinds Intact
- Caustic soda prices remained very strong: High energy prices in Europe and plant issues in the US kept international caustic prices elevated. Realizations grew in Q4 as lower-price legacy contracts rolled off and were replaced with new contracts at higher prices.
- Capacity restoration underway: Work has started on restoring caustic capacity to the full installed level of 119,000 tons per annum, from the current 100,000 tons. The additional ~20,000 tons is expected online by FY2024.
- Chloromethanes demand held firm: The product continued to feed into strong agrochemical and pharma end-markets. The medium-term outlook is supported by the transition to more sustainable refrigerant gases by AC and refrigerator manufacturers.
Capex Pipeline & Capital Allocation
- Announced projects are on track: Suspension PVC debottlenecking (10% capacity addition) will be fully online by end of Q1 FY2023, with another 25,000 tons in FY23 and full 30,000-ton impact in FY24. Paste PVC capacity expansion (41,000 tons) and the CMC multipurpose plant are both slated for FY2024. Caustic soda capacity restoration also targets FY2024.
- Combined project revenue impact: On a full-year basis once all projects are commissioned around mid-to-end FY2024, management expects an incremental ₹1,700–1,800 Cr in sales. Near-term projects (suspension PVC debottlenecking and hydrogen peroxide ramp-up) should add ₹400–500 Cr in FY23.
- More is coming: Management is "seriously looking at a few capex opportunities" beyond what has been announced, including on the suspension PVC side. Clarity is expected "over the next couple of quarters," after which a clear announcement on both the future capex plan and capital allocation will follow.
- Debt policy: Debt is considered an integral part of the capital structure. Management is comfortable with a debt level that does not impact the credit rating and wants to retain the AA-/AA level. The CRISIL long-term rating was recently upgraded to AA- stable.
Ramkumar Shankar: "We are seriously looking at a few capex opportunities, which are over and beyond what we have already announced and what we are already working on, so those are plans that we are looking at which possibly we will have more clarity over the next couple of quarters and when we get the clarity and we understand how much of capital would be required for these projects, then we would come out with the clear announcement on both the future capex plan over and above what we have already announced as also our capital allocation."
Financial Health & Margin Quality
- PAT growth masked by base effect: Q4 PAT was ₹232 Cr, up 29% YoY after excluding ₹185 Cr of JV/associate PAT from Q4 FY2021. The improvement came from slightly higher operating profits and sharply lower finance costs.
- Finance cost dropped sharply: Q4 finance cost fell to ₹35 Cr from ₹92 Cr YoY, driven by lower debt and renegotiated interest rates. Management expects the drop to sharpen further.
- Gross margin percentage is misleading: Absolute gross margin rose to ₹601 Cr in FY22 from ₹545 Cr in FY21, but the percentage declined because the revenue base expanded. Management tracks per-unit contribution, not percentage margins: higher end-product and input prices can still yield higher per-ton margins and improved absolute profitability.
- Working capital swelled on timing: Inventory rose due to nearly 20,000 tons of VCM in transit at year-end. Debtors increased primarily because of higher custom manufacturing sales in the last quarter, while PVC credit periods remain tight at 3–7 days.
N. Muralidharan: "What we track more importantly is the per unit contribution that is what is more important to us because if the price of the end product goes up and price of input also goes up we still get the margins, on a per ton basis, it will flow down to the bottomline as well, but when you look at the gross margin you may assume that the gross margin level has dropped from the compared to the previous year, in reality the profitability of the business in fact would have improved because we would have got a higher per ton margin from that product."
Volume Growth Levers
- Suspension PVC: Ran at 99% capacity utilization in FY22. Debottlenecking will add 25,000 tons in FY23 and the full 30,000-ton impact in FY24.
- Hydrogen peroxide: Ran at close to 50% utilization in FY22. Ramp-up to full capacity is expected in FY23, adding ~15,000 tons.
- Caustic soda: Small volume increase expected from ongoing capacity restoration, with the full 20,000-ton addition coming in FY24.
- Custom manufacturing: Volume growth in FY23 from new products commercialized in FY22 and additional new products to be added during the year, though constrained by overall capacity.
- Paste PVC: 41,000-ton capacity addition at Cuddalore expected on stream in FY2024.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Suspension PVC debottlenecking | 10% capacity addition fully online | End of Q1 FY2022 |
| Hydrogen peroxide ramp-up | Hit full capacity utilization | FY2022-FY2023 |
| Custom manufacturing growth cap | Not expected to cross 20% in FY23 | FY2023 |
| Near-term project sales impact | ₹400–500 Cr incremental sales from suspension PVC debottlenecking and H2O2 ramp-up | FY2023 |
| CMC multipurpose plant Phase 1 | On stream, unlocking significant growth | Q1 FY2023 |
| Paste PVC capacity expansion | 41,000 tons on stream | FY2024 |
| Caustic soda capacity restoration | Full 119,000-ton installed capacity restored | FY2024 |
| Combined project revenue impact | ₹1,700–1,800 Cr incremental sales on full-year basis | FY2024 (mid-to-end commissioning) |
| CMC revenue potential | Incremental ~₹700 Cr, taking total closer to ₹1,000 Cr | Once expansions complete and ramped up |
| Additional capex plan clarity | Clear announcement on future capex and capital allocation | "Next couple of quarters" |
| FY22 EBITDA sustainability | Confident FY22 EBITDA is sustainable and will improve with volume additions if current price levels are maintained | Ongoing |
Key Metrics
| Metric | Q4 FY22 |
|---|---|
| Revenue from operations | ₹1,807 cr, up 35% YoY |
| EBITDA | ₹346 cr, marginal growth of 1% YoY |
| EBITDA margin | 19% |
| Profit after tax | ₹232 cr, up 29% YoY (excluding ₹185 cr PAT from JV/associate in Q4 FY21) |
| Finance cost | ₹35 cr, down from ₹92 cr YoY |
| Suspension PVC paste volume | 87,523 metric tons, surged 13% YoY |
| Suspension PVC revenue growth | 25% YoY |
| Paste PVC sales volume growth | 28% YoY |
| Suspension PVC overall contribution per ton | ~₹22,600, first two months avg ~₹18,000, last month avg ~₹29,000 |
| Custom manufactured chemicals revenue growth | Slightly above 50% YoY |
| Custom manufactured chemicals contribution margin | 40%–50% |
| CCVL (suspension PVC) EBITDA | ₹156 cr |
| Chemplast Sanmar (specialty plus non-specialty) EBITDA | ₹191 cr |
| Suspension PVC capacity utilization | 99% (FY22) |
| Chloromethanes capacity utilization | 99% (FY22) |
| Hydrogen peroxide capacity utilization | Close to 50%, expected to ramp to full in FY23 |
| Suspension PVC CFR India delta over VCM | $325–$400 per ton stable range |